This Biotech Stock Winner Is Up 72%, but Trim Signals Reset
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
Explore four Fund Activity articles that summarize recent capital moves, new fund bets, and biotech deals. This page helps you spot trends that affect your investments.
9 articlesA biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
Institutional funds often reveal conviction through large stake increases. This article explains the implications whe...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...
Sable Offshore stock tanked over the last year as oil markets swung and investors weighed long-term offshore exposure...
Sotera Health has delivered a solid return over the last 12 months. Yet a sizable fund recently unloaded millions of ...
A notable stake change in Victoria’s Secret & Co. raises questions for investors. This article explains what the capi...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...